Inhibitory effect of free sialic acid on complement activation and its significance in hypocomplementemic glomerulonephritis

Journal of Clinical Laboratory Analysis

Volumn 13, Issue 4, 1999, Pages 173-179

  Fujita, Takayuki ^a   Satomura, Atsushi ^a   Hidaka, Mutsuko ^a   Ohsawa, Isao ^a   Endo, Morito ^a   Ohi, Hiroyuki ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute post infectious glomerulonephritis; Hypocomplementemia; Membranoproliferative glomerulonephritis; Sialic acid; Systemic lupus erythematosus

Indexed keywords

SIALIC ACID;

ACUTE GLOMERULONEPHRITIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; HUMAN; IMMUNOASSAY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PATHOGENESIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; BLOOD PROTEINS; CHRONIC DISEASE; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT SYSTEM PROTEINS; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HEMOLYSIS; HUMANS; N-ACETYLNEURAMINIC ACID; PROTEIN BINDING; RABBITS;

ORYCTOLAGUS CUNICULUS;

EID: 0032995748     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1999)13:4<173::AID-JCLA6>3.0.CO;2-U     Document Type: Article

References (21)

1. Leibowitch L, Halwachs M, Wattel S. Glomerulonephritis and hypocomplementemia: pathophysiology and pathogenic implications. In: Hamburger J, Crosnier J, Grünfeld J, Maxwell MH, editors. Advances in Nephrology, vol. 9. Chicago: Year Book Medical Publishers; 1980. p 295-314.
2. Ohi H. The role of complement in membrano-proliferative glomerulonephritis (MPGN). Jpn J Nephrol 1987;20:1125-1139.
3. Glassock RJ. Clinical features of immunologic glomerular disease. In: Wilson CB, editor. Immunologic Mechanisms of Renal Disease. London: Churchill Livingstone; 1979. p 165-179.
4. Fujita T. Clinical study of complement breakdown products in patients with hypocomplementemic glomerulonephritis. Jpn J Nephrol 1982; 24:845-853.
5. Seki M, Ohi H, Kojima H, Fujita T, Hatano M. A case of Hypocomplementemic mesangiocapillary glomerulonephritis: appearance of C3 NeF and another factor. Jpn J Nephrol 1987;29:585-588.
6. Fujita T, Ohi H, Seki M, Hatano M. Clinical evaluation and characterization of a unique C3 breakdown factor detected in a patient with acute glomerulonephritis. Nephron 1987;47:56-61.
7. Schauer R. Chemistry, metabolism, and biological functions of sialic acids. In: Tipson RS, Horton D, editors. Advances in Carbohydrate Chemistry and Biochemistry, vol. 40. London: Academic Press; 1982. p 131-234.
8. Shauer R. Sialic acids and their role as biological masks. In: Hall J, editor. Trends in Biochemical Science, vol. 10. Amsterdam: Elsevier Science Publishers; 1985. p 357-360.
9. Ourth DD, Bachinski LM. Bacterial sialic acid modulates activation of the alternative complement pathway of channel catfish. Develop Comp Immunol 1987;11:551-564.
10. Pangburn MK, Müller-Eberhard HJ. Complement C3 convertase: cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells. Proc Natl Acad Sci U S A 1978;75:2416-2420.
11. Reutter W, Köttgen E, Bauer C, Gerok W. Biological significance of sialic acid. In: Schauer R, editor. Sialic acids: chemistry, metabolism and function (Cell Biology Monograph, vol. 10). New York: Springer-Verlag; 1980. p 263-305.
12. Schauer R, Shukla AK, Schröder C, Müller E. The anti-recognition function of sialic acid: studies with erythrocytes and macrophages. Pure Appl Chem 1984;56:907-921.
13. Tack BF, Prahl JW. Fifth component of human complement: purification from plasma and polypeptide chain structure. Biochemistry 1976;15:4513-4521.
14. Mancini G, Carbonara A, Hermans J. Immunological quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965;2:235-253.
15. Tamerius JD, Pangburn MK, Müller-Eberhard. Detection of a neoantigen on human iC3b and C3d by monoclonal antibody. J Immunol 1985;135:2015-2019.
16. Platts-Mills TAE, Ishizaka K. Activation of the alternative pathway of human complement by rabbit cells. J Immunol 1974; 113:348-358.
17. Harrison RA, Lachmann PJ. Complement technology. In: Weir DM, editor. Handbook of experimental immunology, 4th edition. Oxford: Blackwell; 1986. p 5A. 1-23.9.
18. Hammond KS, Papermaster DS. Fluorometric assay of sialic acid in the picomole range: a modification of the thiobarbituric acid assay. Analyt Biochem 1976;74:292-297.
19. Sugahara K, Sugimoto K, Nomura O, Usui T. Enzymatic assay of serum sialic acid. Clin Chim Acta 1980;108:493-498.
20. Hess EL, Coburn AF, Bates RC, Murphy P. A new method for measuring sialic acid levels in serum and its application to rheumatic fever. J Clin Invest 1957;36:449-455.
21. Pilatte Y, Bignon J, Lambré CR. Sialic acids as important molecules in the regulation of the immune system: pathophysiological implications of sialidases in immunity. Glycobiology 1993;3:201-217.